Variant-Specific Analysis Reveals a Novel Long-Range RNA-RNA Interaction in SARS-CoV-2 Orf1a

Int J Mol Sci. 2022 Sep 21;23(19):11050. doi: 10.3390/ijms231911050.

Abstract

Since the start of the COVID-19 pandemic, understanding the pathology of the SARS-CoV-2 RNA virus and its life cycle has been the priority of many researchers. Currently, new variants of the virus have emerged with various levels of pathogenicity and abundance within the human-host population. Although much of viral pathogenicity is attributed to the viral Spike protein's binding affinity to human lung cells' ACE2 receptor, comprehensive knowledge on the distinctive features of viral variants that might affect their life cycle and pathogenicity is yet to be attained. Recent in vivo studies into the RNA structure of the SARS-CoV-2 genome have revealed certain long-range RNA-RNA interactions. Using in silico predictions and a large population of SARS-CoV-2 sequences, we observed variant-specific evolutionary changes for certain long-range RRIs. We also found statistical evidence for the existence of one of the thermodynamic-based RRI predictions, namely Comp1, in the Beta variant sequences. A similar test that disregarded sequence variant information did not, however, lead to significant results. When performing population-based analyses, aggregate tests may fail to identify novel interactions due to variant-specific changes. Variant-specific analyses can result in de novo RRI identification.

Keywords: COVID-19; RNA structure; RNA-RNA interaction; SARS-CoV-2; compensatory mutations; viral evolution.

MeSH terms

  • Angiotensin-Converting Enzyme 2 / genetics
  • COVID-19* / genetics
  • Humans
  • Pandemics
  • Polyproteins / genetics
  • RNA, Viral / genetics
  • SARS-CoV-2* / genetics
  • Spike Glycoprotein, Coronavirus / metabolism
  • Viral Proteins / genetics*

Substances

  • ORF1ab polyprotein, SARS-CoV-2
  • Polyproteins
  • RNA, Viral
  • Spike Glycoprotein, Coronavirus
  • Viral Proteins
  • spike protein, SARS-CoV-2
  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

The IUPUI Open Access Fund covered publishing costs, provided by the IUPUI Library.